Dr Fatima H. Labeed earned her first degree in Biochemistry from the University of London, followed by a Masters in Clinical Biochemistry with Molecular Biology and a PhD, both from the University of Surrey. She previously worked in industry at Pfizer’s Parke-Davis Research Centre in Cambridge and held visiting positions at the University of Bergen and the University of California Irvine. Her research has focused on the applications of dielectrophoresis to cell biology, including the detection of oral cancer through discrimination between normal and cancerous epithelial cells, studies on neural and mesenchymal stem cells, and the development of drug assays to monitor electrophysiological changes. Additional work has examined circadian rhythms in red blood cells and the electrophysiological properties of cells in contexts such as malaria infection, anemia, and potential biomarkers for conditions including ME/CFS. She has received research funding from sources including NIHR and EPSRC, as well as industry partners, and has delivered invited seminars at institutions such as Stanford University. Dr Labeed is currently Associate Professor in the Department of Biology at United Arab Emirates University.
She has contributed to publications on topics including circadian rhythmicity in murine blood, extracellular potentials in red blood cells, and changes in cell electrophysiology related to osteoarthritis and chondrocyte transformation. She has acted as Journal Administrator for IEEE Transactions on Nanobioscience and is a member of the British and American Associations for Cancer Research and the Biophysical Society. Research collaborations have included work with the Eastman Dental Institute, University of California Irvine, University of Bergen, and teams at Brunel University London on ME/CFS diagnostic approaches based on cell electrophysiology.